CHEK2 and colorectal cancer: To further investigate the possibility to take advantage of DDR to target acid-exposed cancer cells, we next examined the phosphorylation of ATM and ATR, and downstream checkpoint kinases CHK1 and CHK2 in colorectal cancer HCT116 cells cultured at pHe 6.5 or pHe 7.4.